The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Expected To Change Between 2026 And 2030?
The market size for prostate-specific membrane antigen (psma) theranostic kits has experienced significant expansion recently. This market is projected to expand from $1.05 billion in 2025 to $1.19 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.9%. Historically, this growth has been driven by factors such as the rising incidence of prostate cancer, advancements in nuclear medicine imaging, increasing adoption of molecular diagnostics, early clinical validation of psma targeting, and the expansion of oncology research programs.
The prostate-specific membrane antigen (psma) theranostic kits market is anticipated to undergo significant expansion in the coming years. It is forecast to achieve a valuation of $1.99 billion in 2030, expanding at a compound annual growth rate (CAGR) of 13.5%. The projected surge during this period is primarily driven by an increasing need for tailored cancer treatments, growing investments in theranostics, the expansion of nuclear medicine infrastructure, the rising application of precision oncology diagnostics, and more frequent regulatory approvals for targeted therapies. Noteworthy trends for the forecast period include the increasing adoption of targeted radioligand therapies, the growing use of psma-based precision diagnostics, enhanced integration of imaging and therapy workflows, the expansion of personalized oncology treatment kits, and a sharpened focus on companion diagnostics.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30362&type=smp
Which Economic Or Industry Drivers Are Impacting The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?
The increasing occurrence of prostate cancer is anticipated to fuel the expansion of the prostate-specific membrane antigen (PSMA) theranostic kits market in the future. Prostate cancer is defined as a malignancy originating in the prostate gland, which is a small gland situated in men beneath the bladder and before the rectum. The increasing frequency of prostate cancer can be attributed to the aging demographic, given that the likelihood of developing this cancer rises considerably with advancing age. Prostate-specific membrane antigen (PSMA) theranostic kits improve the management of prostate cancer through the provision of targeted diagnostic tools, proving highly suitable for prompt diagnosis and customized therapeutic strategies. These kits boost diagnostic precision by integrating PSMA-specific ligands with radiotracers, thereby aiding in more effective disease surveillance and treatment direction. For example, reports from November 2023 by the American Cancer Society, a US-based non-profit organization, projected around 313,780 new cases of prostate cancer and 35,770 deaths in the United States by 2025. Consequently, the growing incidence of prostate cancer serves as a key impetus for the expansion of the prostate-specific membrane antigen (PSMA) theranostic kits market.
How Is The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Structured Across Different Segments?
The prostate-specific membrane antigen (psma) theranostic kits market covered in this report is segmented –
1) By Product Type: Diagnostic Kits, Therapeutic Kits, Combined Theranostic Kits
2) By Application: Prostate Cancer, Other Cancers
3) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Other End-Users
Subsegments:
1) By Diagnostic Kits: Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography Imaging Kits, Single Photon Emission Computed Tomography Imaging Kits, Companion Diagnostic Kits, Liquid Biopsy Kits
2) By Therapeutic Kits: Radioligand Therapy Kits, Antibody-Based Therapy Kits, Peptide-Based Therapy Kits, Small Molecule Therapy Kits
3) By Combined Theranostic Kits: Integrated Imaging And Therapy Kits, Dual Function Radiopharmaceutical Kits, Prostate-Specific Membrane Antigen (PSMA) Ligand-Based Theranostic Kits, Personalized Treatment Kits
What Industry Trends Are Redefining The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?
Companies operating in the prostate-specific membrane antigen (PSMA) theranostic kits market are prioritizing the creation of innovative solutions, such as PSMA-targeted radioligand kits, to satisfy the growing demand for precision oncology, precise prostate cancer diagnosis, and therapy. PSMA-targeted radioligand kits are medical supplies that combine a ligand specifically designed to bond with Prostate-Specific Membrane Antigen (PSMA) and a radioactive isotope for either diagnostic imaging or targeted therapy of prostate cancer. For example, in March 2025, Telix Pharmaceuticals Limited, an Australia-based radiopharmaceutical company, launched Illuccix, an advanced kit intended for the preparation of Gallium-68 gozetotide injection. This kit allows hospitals and nuclear medicine facilities to label the radionuclide immediately prior to injection for PET imaging of PSMA-positive prostate cancer lesions. The kit features a ready-to-use preparation format, disease-specific targeting, quick imaging capabilities, and compatibility with theranostic workflows, facilitating improved detection of metastatic lesions, treatment planning, and monitoring of therapy response. Its applications include the diagnosis of recurrent or metastatic prostate cancer and informing personalized treatment decisions, marking a significant improvement over conventional imaging or non-targeted therapies.
Which Major Players Dominate The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?
Major companies operating in the prostate-specific membrane antigen (psma) theranostic kits market are Cyclotek (Aust) Pty Ltd, Telix Pharmaceuticals Ltd, Curium Pharma, SOFIE Biosciences Inc., Lantheus Holdings Inc., Eckert & Ziegler SE, NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, AdvanCell Pty Ltd, Alpha‑9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, RadioMedix Inc., Scintomics GmbH, Novartis AG, Bayer AG, POINT Biopharma Inc., Blue Earth Diagnostics
Read the full prostate-specific membrane antigen (psma) theranostic kits market report here:
What Are The Top-Performing Regions Within The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?
North America was the largest region in the prostate-specific membrane antigen (PSMA) theranostic kits market in 2025. The regions covered in the prostate-specific membrane antigen (psma) theranostic kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=30362&type=smp
Browse Through More Reports Similar to the Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market 2026, By The Business Research Company
Prostate Cancer Diagnostics Global Market Report
https://www.thebusinessresearchcompany.com/report/prostate-cancer-diagnostics-global-market-report
Prostate Cancer Nuclear Medicine Diagnostics Global Market Report
Endocrine Peptide Test Global Market Report
https://www.thebusinessresearchcompany.com/report/endocrine-peptide-test-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model